ADAGE CAPITAL PARTNERS GP, L.L.C. - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 128 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,676,000
-67.3%
700,000
-45.9%
0.03%
-66.7%
Q2 2023$35,704,678
-39.3%
1,292,711
-49.5%
0.08%
-40.9%
Q1 2023$58,834,000
+603.0%
2,558,000
+233.5%
0.13%
+560.0%
Q4 2022$8,368,461
+13.7%
767,045
-12.1%
0.02%
+11.1%
Q3 2022$7,360,000
-7.0%
873,045
-12.7%
0.02%0.0%
Q2 2022$7,910,000
-44.3%
1,000,045
+66.7%
0.02%
-33.3%
Q1 2022$14,209,000
-7.7%
600,045
+33.3%
0.03%
-3.6%
Q4 2021$15,392,000
+189.5%
450,045
+50.0%
0.03%
+180.0%
Q3 2021$5,317,000
-78.5%
300,045
-45.5%
0.01%
-79.2%
Q2 2021$24,686,000
+58.8%
550,045
-8.3%
0.05%
+50.0%
Q1 2021$15,541,000
-33.0%
600,045
-47.8%
0.03%
-37.3%
Q4 2020$23,185,000
-53.0%
1,150,045
-54.4%
0.05%
-58.5%
Q3 2020$49,278,000
+26.8%
2,520,600
+14.6%
0.12%
+24.2%
Q2 2020$38,852,000
+1056.3%
2,200,000
+340.0%
0.10%
+1137.5%
Q2 2018$3,360,000
-60.9%
500,000
-50.0%
0.01%
-60.0%
Q1 2018$8,590,000
-79.9%
1,000,000
-51.4%
0.02%
-79.4%
Q4 2017$42,766,000
+17.7%
2,056,0760.0%0.10%
+10.2%
Q3 2017$36,331,000
+56.2%
2,056,0760.0%0.09%
+54.4%
Q2 2017$23,254,000
+9.6%
2,056,076
+24.2%
0.06%
+7.5%
Q1 2017$21,214,000
-37.0%
1,656,076
+8.2%
0.05%
-42.4%
Q4 2016$33,668,000
+0.8%
1,531,076
-3.2%
0.09%0.0%
Q3 2016$33,408,0001,581,0760.09%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$43,400,0003.81%
BVF INC/IL 3,901,759$69,139,0002.70%
COMMODORE CAPITAL LP 498,079$8,826,0002.33%
Altium Capital Management LP 346,000$6,131,0001.61%
Twin Lakes Capital Management, LLC 139,287$2,468,0001.45%
Opaleye Management Inc. 330,222$5,852,0001.09%
EcoR1 Capital, LLC 1,443,800$25,584,0000.89%
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 776,689$13,763,0000.76%
JABODON PT CO 90,656$1,606,0000.66%
Artal Group S.A. 1,500,000$26,580,0000.60%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders